How much funding has Embark raised?

Embark has raised $91.1M in total funding, most recently a Series B round.

Who are Embark's investors?

Embark's investors include Slow Ventures, F-Prime Capital, SoftBank, Founder Collective, Freestyle Capital, Third Kind Venture Capital.

Where is Embark headquartered?

Embark is headquartered in Boston, Massachusetts, United States.

What industry is Embark in?

Embark operates in Biotech, Genomics, Pet Tech, Transportation.

Embark

Closed

Know your dog. Better.

Boston, United States · Founded 2015 · $91.1M raised

YC S11

Headquarters: Boston, Massachusetts
Employees: 1–10
Founded: 2015
Business Model: B2C

Website: letsembark.com
Total Funding: $91.1M
Last Round: $75.0M Series BJul 2021
Rounds: 4

About

Embark Veterinary is a canine genomics and biotechnology company based in Boston, Massachusetts, founded in 2015 by brothers Adam and Ryan Boyko. The company offers dog DNA testing services to consumers, breeders, and veterinary practices. Its flagship products screen for over 400 dog breeds and test for hundreds of genetic health conditions, coat color and trait markers, estimated biological age, and a Relative Finder feature that connects dogs sharing DNA. Embark uses a research-grade microarray platform developed in partnership with Cornell University College of Veterinary Medicine, making it one of the most scientifically rigorous consumer dog DNA tests available. The company also offers gut health tests and targeted nutritional supplements. Embark has helped millions of pet parents better understand their dogs' breed ancestry, health risks, and care needs.

Summary

Embark is a Biotech company based in Boston, United States, founded in 2015. It has raised $91.1M in total across 4 rounds, most recently a $75.0M Series B round in Jul 2021. Investors include Slow Ventures, F-Prime Capital and SoftBank.

LinkedIn X (Twitter)